Cardinal Capital Management Inc (Canada)’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Cardinal Capital Management Inc (Canada)'s BIIB Position: Q2 2022 in Review
Cardinal Capital Management Inc (Canada) sold out of Biogen (BIIB) in Q2 2022, closing a stake of 15 shares — an estimated $3K sold.
Cardinal Capital Management Inc (Canada) first reported a position in BIIB in Q1 2022 and held it in 1 quarter. The position peaked at $3K in Q1 2022. 927 funds tracked by Wall St. Rank hold BIIB as of Q2 2022.
- Cardinal Capital Management Inc (Canada) reported no remaining Biogen position as of Q2 2022 after selling out during the quarter.
- Cardinal Capital Management Inc (Canada) sold 15 Biogen shares in Q2 2022, an estimated $3K.
- Cardinal Capital Management Inc (Canada) first reported a position in Biogen in Q1 2022 and held it in 1 quarter.
- Cardinal Capital Management Inc (Canada)'s Biogen position peaked at $3K in Q1 2022.
- 927 funds tracked by Wall St. Rank held Biogen as of Q2 2022.
Based on Cardinal Capital Management Inc (Canada)'s 13F filing for Q2 2022, filed 13 Jul 2022.